Enanta Pharmaceuticals (ENTA) Reports Q1 Loss of $42 per Share

Enanta Pharmaceuticals Inc. (ENTA) released fiscal first-quarter results on February 9, 2026, reporting a loss of $11.9 million, or 42 cents per share, on revenue of $18.6 million.